KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of Deferred ChargesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)DivestmentsDividends Paid - CommonFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Tenet Healthcare (THC) Capital Expenditures: 2012-2025

Historic Capital Expenditures for Tenet Healthcare (THC) over the last 14 years, with Q3 2025 value amounting to $280.0 million.

  • Tenet Healthcare's Capital Expenditures rose 2962.96% to $280.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $819.0 million, marking a year-over-year decrease of 261.59%. This contributed to the annual value of $931.0 million for FY2024, which is 2396.8% up from last year.
  • According to the latest figures from Q3 2025, Tenet Healthcare's Capital Expenditures is $280.0 million, which was up 2962.96% from $193.0 million recorded in Q2 2025.
  • Tenet Healthcare's 5-year Capital Expenditures high stood at $330.0 million for Q4 2024, and its period low was $111.0 million during Q3 2021.
  • Over the past 5 years, Tenet Healthcare's median Capital Expenditures value was $176.0 million (recorded in 2023), while the average stood at $197.3 million.
  • Within the past 5 years, the most significant YoY rise in Tenet Healthcare's Capital Expenditures was 8313.25% (2021), while the steepest drop was 3351.65% (2021).
  • Tenet Healthcare's Capital Expenditures (Quarter) stood at $304.0 million in 2021, then decreased by 4.61% to $290.0 million in 2022, then fell by 28.28% to $208.0 million in 2023, then soared by 58.65% to $330.0 million in 2024, then fell by 15.15% to $280.0 million in 2025.
  • Its last three reported values are $280.0 million in Q3 2025, $193.0 million for Q2 2025, and $173.0 million during Q1 2025.